Literature DB >> 32966900

Plasma Cell Pododermatitis Associated With Feline Leukemia Virus (FeLV) and Concomitant Feline Immunodeficiency Virus (FIV) Infection in a Cat.

Giovana Biezus1, Thierry Grima de Cristo1, Michele Ferraz da Silva Schade1, Paulo Eduardo Ferian1, Felipe Carniel1, Luiz Claudio Miletti1, Aline da Rosa Maciel1, Renata Assis Casagrande2.   

Abstract

This report aims to describe one case of plasma cell pododermatitis associated with feline leukemia virus (FeLV) and concomitant feline immunodeficiency virus (FIV) infection in a cat. A 2-year-old, intact male, mixed-breed cat was presented with alopecia, skin peeling, and erythematous swelling in the left metacarpal paw pad. Swelling, softening, ulceration with secondary crusts, and erythematous to violaceous discoloration were observed in multiple metacarpal, metatarsal, and digital paw pads. Complete blood count and serum biochemistry were analyzed. FeLV antigenemia and FIV seropositivity were assessed by immunoassay (enzyme-linked immunosorbent assay). Nested-PCR was used to detect FIV and FeLV proviral DNA in blood cells. Histopathological examination and anti-FeLV and anti-FIV immunohistochemical were performed on paw pad biopsies. According to clinical and histopathological findings, a diagnosis of plasma cell pododermatitis was made. The cat was FIV and FeLV seropositive. The immunohistochemical of paw pad biopsies revealed FeLV positivity and FIV negativity. This study provides reference for further investigations about feline plasma cell pododermatitis and highlights retrovirus infection as a potential factor associated with this disease.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  dermatitis; feline medicine; immune-mediated disease; retrovirus

Mesh:

Year:  2020        PMID: 32966900     DOI: 10.1016/j.tcam.2020.100475

Source DB:  PubMed          Journal:  Top Companion Anim Med        ISSN: 1946-9837


  1 in total

1.  Feline plasma cell pododermatitis.

Authors:  Gabrielle Brosseau
Journal:  Can Vet J       Date:  2022-05       Impact factor: 1.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.